Cite

1. Moodie DS. The Global Burden of Cardiovascular Disease. Congenital heart disease. 2016;11(3):213. DOI: 10.1111/chd.1238310.1111/chd.12383Search in Google Scholar

2. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocar-dial infarction. New England J Med. 2003;349(8):733-42. DOI: 10.1056/NEJMoa02514210.1056/NEJMoa025142Search in Google Scholar

3. Zimmerman BJ, Granger DN. Reperfusion Injury. Surg Clin North Am. 1992;72(1):65-83. DOI: 10.1016/S0039-6109(16)45628-810.1016/S0039-6109(16)45628-8Search in Google Scholar

4. Paul A Lapchak JHZ. Neuroprotective therapy for stroke and ischemic disease 2017. DOI: 10.1007/978-3-319-45345-310.1007/978-3-319-45345-3Search in Google Scholar

5. Pearson PJ, Schaff HV, Vanhoutte PM. Long-term impairment of endothelium-dependent relaxations to aggregating platelets after reperfusion injury in canine coronary arteries. Circulation. 1990;81(6):1921-7. DOI: 10.1161/01.CIR.81.6.192110.1161/01.CIR.81.6.19212344684Search in Google Scholar

6. İkizler M DS, Erkasap N, Kaygısız Z, Sevin B, Kural T. The Hemodynamic Efficacy Of Resveratrol On Reper-fusion Injury In Isolated Rat Hearts. Turkish Journal Of Thoracic And Cardiovascular Surgery. 2003;11:91-5.Search in Google Scholar

7. Nazari A, Sadr SS, Faghihi M, Imani A, Moghimian M. The cardioprotective effect of different doses of vasopressin (AVP) against ischemia-reperfusion injuries in the anesthetized rat heart. Peptides. 2011;32(12):2459-66. DOI: 10.1016/j.peptides.2011.10.02310.1016/j.peptides.2011.10.02322079221Search in Google Scholar

8. Robicsek F, Schaper J. Reperfusion injury: fact or myth? J Card Surg. 1997;12(3):133-7; discussion 8. DOI: 10.1111/j.1540-8191.1997.tb00112.x10.1111/j.1540-8191.1997.tb00112.x9395941Search in Google Scholar

9. Kurutas EB. The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state. Nutrition J. 2016;15(1):71. DOI: 10.1186/s12937-016-0186-510.1186/s12937-016-0186-5496074027456681Search in Google Scholar

10. Qu X, Chen X, Shi Q, Wang X, Wang D, Yang L. Resveratrol alleviates ischemia/reperfusion injury of diabetic myocardium via inducing autophagy. Exp Ther Med. 2019;18(4):2719-25. DOI: 10.3892/etm.2019.784610.3892/etm.2019.7846675541331555372Search in Google Scholar

11. Mao ZJ, Lin H, Hou JW, Zhou Q, Wang Q, Chen YH. A Meta-Analysis of Resveratrol Protects against Myocar-dial Ischemia/Reperfusion Injury: Evidence from Small Animal Studies and Insight into Molecular Mechanisms. Oxid Med Cell Longev. 2019;2019:5793867. DOI: 10.1155/2019/579386710.1155/2019/5793867651203531182995Search in Google Scholar

12. Yulug B, Hanoglu L, Khanmammadov E, Duz OA, Polat B, Hanoglu T, et al. Beyond The Therapeutic Effect of rTMS in Alzheimer’s Disease: A Possible Neuroprotective Role of Hippocampal BDNF? : A Minireview. Mini Rev Med Chem. 2018;18(17):1479-85. DOI: 10.2 174/138955751766617092716253710.2174/1389557517666170927162537Search in Google Scholar

13. Liu FC, Tsai HI, Yu HP. Organ-Protective Effects of Red Wine Extract, Resveratrol, in Oxidative Stress-Mediated Reperfusion Injury. Oxid Med Cell Longev. 2015;2015:568634. DOI: 10.1155/2015/56863410.1155/2015/568634Search in Google Scholar

14. Kazemirad H, Kazerani HR. Cardioprotective effects of resveratrol following myocardial ischemia and reper-fusion. Molec biol reports. 2020;47(8):5843-50. DOI: 10.1007/s11033-020-05653-710.1007/s11033-020-05653-7Search in Google Scholar

15. de la Lastra CA, Villegas I. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochemical Society transactions. 2007;35(Pt 5):1156-60. DOI: 10.1042/BST035115610.1042/BST0351156Search in Google Scholar

16. Xu H, Cheng J, Wang X, Liu H, Wang S, Wu J, et al. Resveratrol pretreatment alleviates myocardial ischemia/reperfusion injury by inhibiting STIM1-mediated intracellular calcium accumulation. J Physiol Biochem. 2019;75(4):607-18. DOI: 10.1007/s13105-019-00704-510.1007/s13105-019-00704-5Search in Google Scholar

17. Arinno A, Apaijai N, Chattipakorn SC, Chattipakorn N. The roles of resveratrol on cardiac mitochondrial function in cardiac diseases. Eur J Nut. 2021;60(1):29-44. DOI: 10.1007/s00394-020-02256-710.1007/s00394-020-02256-7Search in Google Scholar

18. Fourny N, Lan C, Sérée E, Bernard M, Desrois M. Protective Effect of Resveratrol against Ischemia-Reperfusion Injury via Enhanced High Energy Compounds and eNOS-SIRT1 Expression in Type 2 Diabetic Female Rat Heart. Nutrients. 2019;11(1):105. DOI: 10.3390/nu1101010510.3390/nu11010105Search in Google Scholar

19. Das DK, Maulik N. Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Molecular interventions. 2006;6(1):36-47. DOI: 10.1124/mi.6.1.710.1124/mi.6.1.7Search in Google Scholar

20. Zweier JL. Measurement of superoxide-derived free radicals in the reperfused heart. Evidence for a free radical mechanism of reperfusion injury. J Biol Chem. 1988;263(3):1353-7. DOI: 10.1016/S0021-9258(19)57309-410.1016/S0021-9258(19)57309-4Search in Google Scholar

21. Hung LM, Su MJ, Chu WK, Chiao CW, Chan WF, Chen JK. The protective effect of resveratrols on ischaemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy. British J Pharmacol. 2002;135(7):1627-33. DOI: 10.1038/sj.bjp.070463710.1038/sj.bjp.0704637157330211934802Search in Google Scholar

22. Moskaug J, Carlsen H, Myhrstad MC, Blomhoff R. Polyphenols and glutathione synthesis regulation. American J Clin Nut. 2005;81(1 Suppl):277s-83s. DOI: 10.1093/ajcn/81.1.277S10.1093/ajcn/81.1.277SSearch in Google Scholar

23. Brito PM, Mariano A, Almeida LM, Dinis TC. Resveratrol affords protection against peroxynitrite-mediated endothelial cell death: A role for intracellular glutathione. Chemico-biological interactions. 2006;164(3):157-66. DOI: 10.1016/j.cbi.2006.09.00710.1016/j.cbi.2006.09.007Search in Google Scholar

24. Shen C, Cheng W, Yu P, Wang L, Zhou L, Zeng L, et al. Resveratrol pretreatment attenuates injury and promotes proliferation of neural stem cells following oxygen-glucose deprivation/reoxygenation by upregulating the expression of Nrf2, HO-1 and NQO1 in vitro. Mol Med Reports. 2016;14(4):3646-54. DOI: 10.3892/mmr.2016.567010.3892/mmr.2016.5670Search in Google Scholar

25. Cheng L, Jin Z, Zhao R, Ren K, Deng C, Yu S. Resveratrol attenuates inflammation and oxidative stress induced by myocardial ischemia-reperfusion injury: role of Nrf2/ARE pathway. Int J Clin Exp Med. 2015;8(7):10420-8.Search in Google Scholar

26. Caglayan B, Kilic E, Dalay A, Altunay S, Tuzcu M, Erten F, et al. Allyl isothiocyanate attenuates oxidative stress and inflammation by modulating Nrf2/HO-1 and NF-κB pathways in traumatic brain injury in mice. Molec Biol Rep. 2019;46(1):241-50. DOI: 10.1007/s11033-018-4465-410.1007/s11033-018-4465-4Search in Google Scholar

27. Verzijl D, Peters SL, Alewijnse AE. Sphingosine-1-phosphate receptors: zooming in on ligand-induced intracellular trafficking and its functional implications. Molecules and cells. 2010;29(2):99-104. DOI: 10.1007/s10059-010-0041-z10.1007/s10059-010-0041-zSearch in Google Scholar

28. Kluk MJ, Hla T. Role of the sphingosine 1-phosphate receptor EDG-1 in vascular smooth muscle cell proliferation and migration. Circ Res. 2001;89(6):496-502. DOI: 10.1161/hh1801.09633810.1161/hh1801.096338Search in Google Scholar

29. Maceyka M, Harikumar KB, Milstien S, Spiegel S. Sphingosine-1-phosphate signaling and its role in disease. Trends in cell biology. 2012;22(1):50-60. DOI: 10.1016/j.tcb.2011.09.00310.1016/j.tcb.2011.09.003Search in Google Scholar

30. Snider AJ. Sphingosine kinase and sphingosine-1-phosphate: regulators in autoimmune and inflammatory disease. Int J Clin Rheum. 2013;8(4). DOI: 10.2217/ijr.13.4010.2217/ijr.13.40Search in Google Scholar

31. Fridovich I. Superoxide dismutases. Advances in enzymology and related areas of molecular biology. 1974;41(0):35-97. DOI: 10.1002/9780470122860.ch210.1002/9780470122860.ch2Search in Google Scholar

32. Ernest Beutler. Red Cell Metabolism. A Manual of Biochemical Methods 2nd ed. ed. New York: Grune and Stratton Inc 1984. 68-70 pSearch in Google Scholar

33. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95(2):351-8. DOI: 10.1016/0003-2697(79)90738-310.1016/0003-2697(79)90738-3Search in Google Scholar

34. Annapurna A, Mudagal MP, Ansari A, Rao AS. Cardioprotective activity of chalcones in ischemia/reperfusion-induced myocardial infarction in albino rats. Exp Clin Cardiol. 2012;17(3):110-4.Search in Google Scholar

35. Sener G, Tuğtepe H, Yüksel M, Cetinel S, Gedik N, Yeğen BC. Resveratrol improves ischemia/reper-fusion-induced oxidative renal injury in rats. Arch Med Res. 2006;37(7):822-9. DOI: 10.1016/j.arcmed.2006.04.00310.1016/j.arcmed.2006.04.00316971220Search in Google Scholar

36. Aktaş HS, Ozel Y, Ahmad S, Pençe HH, Ayaz-Adakul B, Kudas I, et al. Protective effects of resveratrol on hepatic ischemia reperfusion injury in streptozotocin-induced diabetic rats. Mol Cell Biochem. 2019;460(1-2):217-24. DOI: 10.1007/s11010-019-03582-z10.1007/s11010-019-03582-z31280437Search in Google Scholar

37. Dong W, Yang R, Yang J, Yang J, Ding J, Wu H, et al. Resveratrol pretreatment protects rat hearts from ischemia/reperfusion injury partly via a NALP3 inflammasome pathway. Int J Clin Exp Pathol. 2015;8(8):8731-41.Search in Google Scholar

38. Nusshold C, Uellen A, Bernhart E, Hammer A, Damm S, Wintersperger A, et al. Endocytosis and intracellular processing of BODIPY-sphingomy-elin by murine CATH.a neurons. Biochim Biophys Acta. 2013;1831(12):1665-78. DOI: 10.1016/j. bbalip.2013.08.007Search in Google Scholar

eISSN:
2284-5623
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Life Sciences, Molecular Biology, Biochemistry, Human Biology, Microbiology and Virology